Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Beximco Pharmaceuticals Limited has successfully appealed to the Bangladesh Supreme Court, leading to the immediate lifting of its trading suspension on AIM. The Court’s decision exempts Beximco Pharma from a previous order to appoint a receiver for the group. The High Court has been directed to resolve a related pending case within two weeks.
For further insights into GB:BXP stock, check out TipRanks’ Stock Analysis page.